Dachaigh › Aillse Sgamhain Neo-chealla-beag › Illinois › Evanston
Sgrùdaidhean clionaigeach Aillse Sgamhain Neo-chealla-beag ann an Evanston, IL
Tha 22 sgrùdaidhean airson Aillse Sgamhain Neo-chealla-beag a’ lorg phàirtichean aig làraichean ann agus timcheall air Evanston (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
A’ fastadhÌre 3
- NorthShore University HealthSystem-Evanston Hospital, Evanston
- NorthShore University HealthSystem-Glenbrook Hospital, Glenview · 5 mìle air falbh
- Advocate Lutheran General Hospital, Park Ridge · 8 mìle air falbh
- agus 1 a bharrachd
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
A’ fastadhÌre 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mìle air falbh
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
A’ fastadhÌre 3
- Endeavor Health, Evanston
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
A’ fastadhÌre 3
- North Shore University Health System ( Site 4014), Evanston
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A’ fastadhÌre 3
- Illinois Cancer Specialists, Niles · 6 mìle air falbh
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
A’ fastadhÌre 3
- Illinois Cancer Specialists, Niles · 6 mìle air falbh
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A’ fastadhÌre 3
- Advocate Lutheran General Hospital, Park Ridge · 8 mìle air falbh
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A’ fastadhÌre 2
- Illinois Cancer Specialists /ID# 274678, Niles · 6 mìle air falbh
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
A’ fastadhÌre 3
- Clinical Study Site, Evanston
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A’ fastadhÌre 2/3
- USOR - Illinois Cancer Specialists - Niles, Niles · 6 mìle air falbh
- Advocate Medical Group Oncology, Park Ridge · 8 mìle air falbh
SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation
A’ fastadhSgrùdadh amharc
- Orchard Healthcare Research Inc., Skokie · 2 mìle air falbh
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
A’ fastadhÌre 3
- Orchard Healthcare Research Inc. ( Site 0115), Skokie · 2 mìle air falbh
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
A’ fastadhÌre 3
- Research Site, Niles · 6 mìle air falbh
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
A’ fastadhÌre 3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mìle air falbh
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
A’ fastadhÌre 2
- Advocate Aurora Health, Park Ridge · 8 mìle air falbh
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
A’ fastadhÌre 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mìle air falbh
- Advocate Lutheran General Hospital, Park Ridge · 8 mìle air falbh
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A’ fastadhÌre 3
- Research Site, Evanston
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
A’ fastadhÌre 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mìle air falbh
- Advocate Lutheran General Hospital, Park Ridge · 8 mìle air falbh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
A’ fastadhÌre 2
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mìle air falbh
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
A’ fastadhÌre 2/3
- Northwestern Medicine Glenview Outpatient Center, Glenview · 5 mìle air falbh
- Advocate Lutheran General Hospital, Park Ridge · 8 mìle air falbh
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
A’ fastadhSgrùdadh amharc
- Advocate Lutheran General Hospital, Park Ridge · 8 mìle air falbh
GEMINI-NSCLC: NSCLC Biomarker Study
A’ fastadhSgrùdadh amharc
- Northwestern University, Evanston
Sgrùdaidhean Aillse Sgamhain Neo-chealla-beag ann am bailtean eile
- Houston, TX145 sgrùdaidhean
- New York City, NY120 sgrùdaidhean
- Arlington, VA104 sgrùdaidhean
- Nashville, TN97 sgrùdaidhean
- Boston, MA90 sgrùdaidhean
- Los Angeles, CA87 sgrùdaidhean
- St. Louis, MO73 sgrùdaidhean
- Chicago, IL61 sgrùdaidhean
- Baltimore, MD60 sgrùdaidhean
- San Antonio, TX59 sgrùdaidhean
- Columbus, OH56 sgrùdaidhean
- Washington, DC55 sgrùdaidhean
Sgrùdaidhean eile ann an Evanston
- Ailseachadh nan Sgamhan19 sgrùdaidhean
- Aillse a' bhroilleach13 sgrùdaidhean
- Leukemia myeloid geur11 sgrùdadh
- Obesity11 sgrùdadh
- Aillse colorectal10 sgrùdaidhean
- Aillse (gach seòrsa)9 sgrùdaidhean
- Ro-throm9 sgrùdaidhean
- Colitis Ulcerative9 sgrùdaidhean
- Aillse Prostata9 sgrùdaidhean
- Galar Crohn9 sgrùdaidhean
- Fàilligeadh a' Chridhe8 sgrùdaidhean
- Fibrillation Atrial8 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 5 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.